Blogs

Quality Systems, Part 2: Developing Effective CAPAs

By Lisa Helmonds, Vice President of Quality and Operations, MWA Consulting, Inc.  In Quality Systems, Part 1: Deviation Management and Investigations, we learned about deviation management and investigations. In this second part of the series, we will...

read more

What is GxP in pharma?

By Lisa Helmonds, Vice President of Quality and Operations, MWA Consulting, Inc.  What is GxP in pharma? If your organization operates in the pharmaceutical industry, encountering GxP quality requirements is unavoidable. In fact, embedding strong and repeatable...

read more

Medical Devices-EU MDR Compliance

By Jason Jegge, Quality and Regulatory Consultant, MWA Consulting, Inc. In follow-up to the How to Transition to the EU MDR Webinar on March 30, 2023, we would like to detail some of the transition highlights and considerations for your attention. First and foremost,...

read more

EU MDR vs. U.S. QSR and the Role of Digitization

By Jason Jegge, Quality and Regulatory Consultant, MWA Consulting, Inc The differences in the ways medical devices are regulated in the U.S. and Europe are subtle but important to understand. This article examines those differences and explains how digitization...

read more

Conducting Remote GxP Audits: Three Keys to Success

By Paula Pilecki, Sr. Director of Project and Audit Management, MWA Consulting, Inc. Introduction The COVID-19 pandemic created unprecedented challenges for quality and compliance professionals in the pharmaceutical, biotech, and medical device industries. Staying on...

read more
Follow MWA on LinkedIn: